These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22965352)

  • 1. Case report: Colonic MALT lymphoma.
    Khan M; Chon D; Patil A
    J Gastrointest Cancer; 2012 Dec; 43(4):622-5. PubMed ID: 22965352
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful rituximab monotherapy for API2-MALT1 fusion positive primary mucosa-associated lymphoid tissue lymphoma of the transverse colon in a patient with liver cirrhosis.
    Yamada M; Kawahara H; Shiroeda H; Tsuchishima M; Masaki Y; Sato K; Takase S
    Scand J Gastroenterol; 2008; 43(6):761-4. PubMed ID: 18569996
    [No Abstract]   [Full Text] [Related]  

  • 3. A solitary polypoid mucosa-associated lymphoid tissue lymphoma in the colon.
    Ye L; Wang Y; Du J; Hu B
    Gastrointest Endosc; 2020 Feb; 91(2):448-449.e1. PubMed ID: 31499042
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytotoxic T cell-mediated gastritis after rituximab treatment for gastric malt lymphoma.
    Stalika E; Kanellis G; Papalexandri A; Iskas M; Vrakidou E; Demonakou M; Anagnostopoulos A; Stamatopoulos K; Papadaki T
    Leuk Lymphoma; 2014 Mar; 55(3):702-5. PubMed ID: 23725385
    [No Abstract]   [Full Text] [Related]  

  • 5. Mucosa-associated lymphoid tissue (MALT) lymphoma presenting as subglottic stenosis: single-agent treatment using rituximab.
    Bielinski C; Luu HS; Mau T
    Otolaryngol Head Neck Surg; 2014 Feb; 150(2):334-5. PubMed ID: 24334958
    [No Abstract]   [Full Text] [Related]  

  • 6. Intralesional rituximab for primary iris lymphoma.
    Demirci H; Grant JS; Elner VM
    JAMA Ophthalmol; 2015 Jan; 133(1):104-5. PubMed ID: 25211092
    [No Abstract]   [Full Text] [Related]  

  • 7. Rituximab-induced remission of a gastric MALT lymphoma.
    Datta YH; Kampalath B; Binion DG
    Leuk Lymphoma; 2004 Jun; 45(6):1297-9. PubMed ID: 15360017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remission of acquired von Willebrand syndrome after successful treatment of gastric MALT lymphoma.
    Biondo F; Matturro A; Santoro C; Leporace A; D'Elia G; Baldacci E; Pignoloni P; Pulsoni A; Foà R; Mazzucconi M
    Haemophilia; 2012 Jan; 18(1):e34-5. PubMed ID: 22059776
    [No Abstract]   [Full Text] [Related]  

  • 9. Synchronous colonic adenoma and intestinal marginal zone B-cell lymphoma associated with Crohn's disease: a case report and literature review.
    Bennani A; Kharrasse G; Achraf M; Wafa K; Zahi I; Imane K; Mohamed B
    BMC Cancer; 2019 Oct; 19(1):966. PubMed ID: 31623635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired C1 esterase inhibitor deficiency in a marginal zone lymphoma patient treated with rituximab.
    Ates O; Sunar V; Babacan T; Akin S; Kertmen N; Altundag K
    J BUON; 2015; 20(1):349. PubMed ID: 25778339
    [No Abstract]   [Full Text] [Related]  

  • 11. Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma.
    Raderer M; Jäger G; Brugger S; Püspök A; Fiebiger W; Drach J; Wotherspoon A; Chott A
    Oncology; 2003; 65(4):306-10. PubMed ID: 14707449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of localized oral MALT lymphoma by rituximab: a case report.
    Yamagata K; Onizawa K; Kojima H; Yoshida H
    Oral Maxillofac Surg; 2008 Dec; 12(4):227-30. PubMed ID: 18830723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intralesional rituximab: a new therapeutic approach for patients with conjunctival lymphomas.
    Ferreri AJ; Govi S; Colucci A; Crocchiolo R; Modorati G
    Ophthalmology; 2011 Jan; 118(1):24-8. PubMed ID: 20709407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended rituximab schedules may result in increased efficacy in pulmonary malt lymphoma.
    Seker M; Bilici A; Ustaalioglu BO; Salman T; Sonmez B; Canpolat NA; Salepci T; Gumus M; Yaylaci M
    Leuk Res; 2009 Sep; 33(9):e154-6. PubMed ID: 19386361
    [No Abstract]   [Full Text] [Related]  

  • 15. [Case report; a case of MALT lymphoma related cryoglobulinemic MPGN responded to combined chemotherapy with rituximab].
    Kurashige M; Yokoo T; Miyazaki Y; Tsuboi N; Hayakawa H; Utsunomiya Y; Hosoya T
    Nihon Naika Gakkai Zasshi; 2011 Apr; 100(4):1054-7. PubMed ID: 21626845
    [No Abstract]   [Full Text] [Related]  

  • 16. Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma of the Colon: A Case Report and a Literature Review.
    Abbas H; Niazi M; Makker J
    Am J Case Rep; 2017 May; 18():491-497. PubMed ID: 28469125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative outcomes of oncologic therapy in gastric extranodal marginal zone (MALT) lymphoma: analysis of the SEER-Medicare database.
    Olszewski AJ; Castillo JJ
    Ann Oncol; 2013 May; 24(5):1352-9. PubMed ID: 23348804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syndrome of inappropriate antidiuretic hormone secretion due to marginal zone lymphoma: responding to rituximab.
    Bockorny B; Dasanu CA
    Clin Lymphoma Myeloma Leuk; 2012 Jun; 12(3):220-2. PubMed ID: 22578816
    [No Abstract]   [Full Text] [Related]  

  • 19. MALT lymphoma of the lacrimal gland in the context of systemic lupus erythematosus: complete remission after treatment with rituximab.
    Tektonidou MG
    Lupus; 2010 Sep; 19(10):1243-5. PubMed ID: 20501524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut perforation in MALT lymphoma of colon.
    Chim CS; Shek TW; Chung LP; Ho J
    Haematologica; 2002 Apr; 87(4):EIM15. PubMed ID: 11940502
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.